Rhythm Pharmaceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.68M-260.60M
Share-based Compensation 0.30M1.17M2.28M6.39M11.88M17.45M20.80M19.83M32.55M39.68M
Gains from Sales and Divestitures 0.07M0.02M0.03M0.16M0.21M0.58M
Gains from Investment Securities 0.92M0.16M1.11M2.62M3.43M2.66M5.74M6.37M6.55M6.61M
Non-cash Items 40.38M0.85M1.45M3.21M3.09M3.94M4.58M
Cash from Operations -6.98M-23.22M-29.46M-62.06M-122.75M-121.98M-146.00M-173.43M-136.16M-113.88M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.14M0.22M0.44M0.83M0.69M
Change in Working Capital
Change in Receivables 1.25M5.20M8.64M3.65M
Change in Inventory 0.01M2.81M5.71M10.12M
Change in Accured Expenses 3.84M-0.47M1.95M6.95M10.51M-6.45M18.31M1.54M14.77M21.92M
Other Working Capital Changes 0.58M-0.04M1.89M6.29M6.38M-0.55M3.34M-6.61M-2.88M5.52M
Investing Activities
Capital Expenditures 0.02M1.06M0.13M0.72M3.38M0.21M0.43M0.28M0.05M
Change in Intangibles 5.67M40.50M
Divestments 7.00M
Change in Acquisitions & Divestments 11.17M17.01M162.17M271.24M245.61M361.25M284.25M354.97M260.64M
Cash from Investing Activities -0.02M-5.11M-110.04M-87.15M-27.97M158.53M-62.16M28.03M-5.67M-48.17M
Financing Activities
Other financing activities 8.90M
Cash from Financing Activities 41.71M167.20M164.69M163.47M2.01M166.48M213.83M74.37M191.24M
Additional items
Exchange Rate Effect -0.14M0.00M
Change in Cash 34.72M-28.33M27.70M15.48M12.75M38.56M-41.68M68.43M-67.60M29.19M
Free Cash Flow -6.99M-24.28M-29.59M-62.78M-126.14M-122.19M-146.44M-173.71M-136.20M-113.88M
Net Cash Flow 34.72M-28.33M27.70M15.48M12.75M38.56M-41.68M68.43M-67.45M29.19M